Marex Stock Doubles on Record Profits, But Can the Rally Continue?

Key Points

• Marex shares have surged 109% over the past 12 months, fueled by six consecutive quarters of record profits since its 2024 IPO.
• Wall Street analysts remain largely bullish, with a Buy consensus rating and an average price target of $82 implying roughly 20% upside.
• Aggressive acquisitions, digital infrastructure investments, and a Bermuda relocation highlight growth, though integration and market volatility risks could challenge the momentum.

Marex Group NASDAQ: MRX has spent the past two years transforming itself from a specialty commodities broker into a much broader financial infrastructure company. Its transformation has worked.

Shares have more than doubled over the past 12 months. It has reported a string of record profits, aggressive acquisitions, and a corporate relocation that all point to a business outgrowing its original footprint. Analysts rate the company a Buy. The question for investors is less about whether Marex's business is working than about whether the stock's run over the past year has already reflected most of that good news.

Marex Shares Surge on Record Growth

Marex's stock reached an all-time high at $79.11 per share in early September before pulling back slightly, though shares remain close to their peak. The stock is up about 80% year-to-date and 109% over the past 12 months.

The recent run-up came after Marex's second-quarter report was released in mid-August, marking the company's sixth consecutive record profit quarter since going public in 2024.

Top-line figures told a clear story. Marex generated $695.8 million of revenue in the second quarter, up 39% from a year earlier. Adjusted profit before tax jumped 56% to $165.9 million.

Adjusted diluted earnings per share (EPS) rose 61% to $1.64, comfortably ahead of what Wall Street had modeled. For the first half of 2026, revenue reached $1.388 billion, a 43% increase from a year earlier, with adjusted profit before tax of $318.6 million, up 57%.

Earnings Growth Continues to Accelerate

This pattern has been showing for some time. Full-year 2025 revenue and earnings both grew substantially from the prior year. Revenue came in at $2.02 billion, up 27%, while adjusted profit before tax climbed 30% to $418.1 million, or $3.86 per diluted share, continuing several years of compounding growth. Margins have widened alongside that growth, with the company's adjusted profitability metrics improving meaningfully compared with the prior year.

Acquisitions Expand Marex’s Reach

With a modest 64-cent annual dividend yielding less than 1%, the investment thesis rests on more than one good quarter. Management has told analysts it expects profit growth to sustain the high end of its long-term target range, with acquisitions contributing a meaningful share of that growth.

Since early 2026, Marex has agreed to or completed four separate deals, expanding its reach into UK equity market making, European equity derivatives, European fixed income market making, and clearing operations in Singapore, adding substantial client balances and deeper access to Chinese markets.

On the infrastructure side, management is building out new capabilities around treasury cross-margining, stablecoin collateral, tokenized repo, and a planned clearing link into prediction markets, bets that global markets will continue to shift digital.

The company also completed a corporate move from England and Wales to Bermuda over the summer, paired with a shareholder request for buyback authority that suggests management sees room to return capital to shareholders.

Analysts Remain Bullish

Wall Street has largely stayed bullish through the stock's surge. With a Buy rating from Wall Street, seven analysts rate the stock a Buy and one a Strong Buy, while just one considers it a Hold.

The average 12-month consensus price target is $82 per share, implying a roughly 20% upside. The highest price target is $90, while the lowest is $75 per share. Over the past three months, there have been a series of target boosts with one upgrade to Strong Buy in June.

Even so, investors are left to wonder whether the market has already priced in a good deal of optimism.

Risks Rise Along With the Valuation

Skepticism is warranted before buying purely on momentum.

Marex’s underlying business carries meaningful operating risk. The company is fundamentally a market maker and clearing house that earns money from trading volume and volatility across commodities, metals, energy, and fixed income, so a sharp slowdown in those markets could pressure revenue quickly.

The firm also regularly issues principal-at-risk structured notes to retail buyers, a reminder that Marex operates in complex derivatives markets rather than a simple brokerage.

Four bolt-on acquisitions inside about a year also raise the usual integration risk that comes with an aggressive dealmaking pace, even as management insists its approach remains disciplined.

Marex Must Keep Delivering

For growth-minded investors, Marex still tells a compelling story as a diversifying, increasingly digital-minded financial platform that is compounding earnings faster than many of its peers in the space.

After nearly doubling over the past year, though, the stock is no longer an undiscovered idea. It is a momentum stock that needs to keep delivering record quarters to justify current levels.

Whether Marex belongs in a portfolio ultimately comes down to how much confidence an investor has that the company's record run of growth has more room to continue.